Creating Futures for Patients with Therapy Resistant Cancers
We are a company committed to the “bench to bedside” translation of research, from the systemic evaluation of mechanisms of therapy resistance to the development of novel therapeutics to treat cancers. Relentless in our pursuit of precision focused innovative solutions, we take on cancers for which there are no effective treatments or only limited ineffective or toxic treatment options: We treat the untreatable.
RIGOROUSNESS – Healthcare can only be meaningfully advanced through exacting science. Breakthroughs can only break through when the science underlying them is strong enough to translate.
RELENTLESSNESS – The fight against cancer is too important to become discouraged. Every new day, we continue looking for treatments that can change the future of oncology.
RELIABILITY – From the research we publish to the relationships we forge, we endeavor to ensure that our partners and the scientific community at large can count on us.
We believe that our pipelines hold the promise of tomorrow’s treatments.
We venture where others won’t.